Skip to content
healthcare.dev

TYVASO

NDC 66302-206, treprostinil, inhalant, from United Therapeutics Corporation.

Product NDC
66302-206
Status
Listed
Labeler
United Therapeutics Corporation
Dosage form
INHALANT
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA022387
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/66302-206 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TREPROSTINIL1.74 mg/2.9mL

Pharmacologic classes

Prostacycline Vasodilator [EPC]; Prostaglandins I [CS]; Vasodilation [PE]

Package NDCNDC-11Package
66302-206-01663020206011 BOX in 1 KIT (66302-206-01) / 28 AMPULE in 1 BOX / 2.9 mL in 1 AMPULE
66302-206-02663020206021 BOX in 1 KIT (66302-206-02) / 28 AMPULE in 1 BOX / 2.9 mL in 1 AMPULE
66302-206-03663020206034 AMPULE in 1 BOX (66302-206-03) / 2.9 mL in 1 AMPULE
66302-206-04663020206041 BOX in 1 KIT (66302-206-04) / 4 AMPULE in 1 BOX / 2.9 mL in 1 AMPULE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/cbc31ab1-a80f-4b50-a3b1-39910b0fb609
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=66302-206

Use it

Look up 66302-206 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/66302-206 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 66302-206. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.